Literature DB >> 15114283

The future of human embryonic stem cell research: addressing ethical conflict with responsible scientific research.

David M Gilbert1.   

Abstract

Embryonic stem (ES) cells have almost unlimited regenerative capacity and can potentially generate any body tissue. Hence they hold great promise for the cure of degenerative human diseases. But their derivation and the potential for misuse have raised a number of ethical issues. These ethical issues threaten to paralyze pubic funding for ES cell research, leaving experimentation in the hands of the private sector and precluding the public's ability to monitor practices, research alternatives, and effectively address the very ethical issues that are cause for concern in the first place. With new technology being inevitable, and the potential for abuse high, government must stay involved if the public is to play a role in shaping the direction of research. In this essay, I will define levels of ethical conflict that can be delineated by the anticipated advances in technology. From the urgent need to derive new ES cell lines with existing technology, to the most far-reaching goal of deriving genetically identical tissues from an adult patients cells, technology-specific ethical dilemmas can be defined and addressed. This staged approach provides a solid ethical framework for moving forward with ES cell research. Moreover, by anticipating the moral conflicts to come, one can predict the types of scientific advances that could overcome these conflicts, and appropriately direct federal funding toward these goals to offset potentially less responsible research directives that will inevitably go forward via private or foreign funding.

Entities:  

Keywords:  Biomedical and Behavioral Research; Genetics and Reproduction

Mesh:

Year:  2004        PMID: 15114283

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  3 in total

Review 1.  Current approaches in regenerative medicine for the treatment of diabetes: introducing CRISPR/CAS9 technology and the case for non-embryonic stem cell therapy.

Authors:  Lauren Coombe; Aamir Kadri; Jessica Ferrer Martinez; Vivas Tatachar; Gary Ian Gallicano
Journal:  Am J Stem Cells       Date:  2018-12-01

2.  Therapeutic potential of stem cells from human exfoliated deciduous teeth infusion into patients with type 2 diabetes depends on basal lipid levels and islet function.

Authors:  Wenwen Li; Xuan Jiao; Jingyun Song; Bingdong Sui; Zhili Guo; Yingji Zhao; Jun Li; Songtao Shi; Qin Huang
Journal:  Stem Cells Transl Med       Date:  2021-03-04       Impact factor: 6.940

Review 3.  Ophthalmic transplantology: posterior segment of the eye--part II.

Authors:  Małgorzata Nita; Barbara Strzałka-Mrozik; Andrzej Grzybowski; Wanda Romaniuk; Urszula Mazurek
Journal:  Med Sci Monit       Date:  2012-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.